Sahar A Helmy

Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment

Sahar A Helmy, Saif El-Mofty, Amal M. El Gayar et al. · Biomedicine & Pharmacotherapy · 2021 · 42 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model

Sahar A Helmy, Mohamed El‐Mesery, Amro El‐Karef et al. · Life Sciences · 2019 · 41 citations

Medicine, Oncology, Pharmacology +16

Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model

Sahar A Helmy, Mohamed El‐Mesery, Amro El‐Karef et al. · Chemico-Biological Interactions · 2017 · 32 citations

Medicine, Oncology, Pharmacology +11

Pramipexole protects against diabetic neuropathy: Effect on oxidative stress, TLR4/IRAK-1/TRAF-6/NF-κB and downstream inflammatory mediators

Nada H. Eisa, Sahar A Helmy, Dalia H. El‐Kashef et al. · International Immunopharmacology · 2024 · 13 citations

Medicine, Neuroscience, Pharmacology +13